Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis

Background. Perioperative intravenous fluids are administered to kidney transplant recipients to maintain hemodynamic stability and graft perfusion; however, the ideal fluid remains uncertain. Although 0.9% saline (saline) is commonly used, its high chloride content causes hyperchloremic metabolic a...

Full description

Saved in:
Bibliographic Details
Main Authors: Susan S. Wan, MBBS, MMed (Clin Epi), FRACP, PhD, Kate Wyburn, MBBS, FRACP, PhD, Steven J. Chadban, PhD, FRACP, FAHMS, Michael G. Collins, MBChB, FRACP, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2025-01-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001687
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850243326239834112
author Susan S. Wan, MBBS, MMed (Clin Epi), FRACP, PhD
Kate Wyburn, MBBS, FRACP, PhD
Steven J. Chadban, PhD, FRACP, FAHMS
Michael G. Collins, MBChB, FRACP, PhD
author_facet Susan S. Wan, MBBS, MMed (Clin Epi), FRACP, PhD
Kate Wyburn, MBBS, FRACP, PhD
Steven J. Chadban, PhD, FRACP, FAHMS
Michael G. Collins, MBChB, FRACP, PhD
author_sort Susan S. Wan, MBBS, MMed (Clin Epi), FRACP, PhD
collection DOAJ
description Background. Perioperative intravenous fluids are administered to kidney transplant recipients to maintain hemodynamic stability and graft perfusion; however, the ideal fluid remains uncertain. Although 0.9% saline (saline) is commonly used, its high chloride content causes hyperchloremic metabolic acidosis and may increase the risks of delayed graft function (DGF) and hyperkalemia. Balanced electrolyte solutions (BES) have a more physiological chloride concentration and may reduce these risks. Previous meta-analyses found insufficient evidence to compare BES with saline for these outcomes; however, new studies have recently been published. In this updated review, we compared the effects of BES with saline on the risk of DGF and hyperkalemia in kidney transplantation. Methods. MEDLINE, Embase, and CENTRAL were searched for randomized controlled trials comparing BES with saline in kidney transplantation. The primary outcomes were DGF and hyperkalemia. Eligible studies were assessed for risk of bias and data were pooled for analysis. The Grading of Recommendations Assessment, Development, and Evaluation framework was used to assess the quality of evidence. Results. Ten studies involving 1532 participants were included. The quality of evidence was high for deceased donor transplantation and very low for living donor transplantation. The relative risk (RR) of DGF associated with BES compared with saline was 0.83 (95% confidence interval [CI], 0.71-0.96; P = 0.01) in deceased donor transplantation. There was no difference in DGF in living donor transplantation (RR 0.79; 95% CI, 0.26-2.41; P = 0.68). There was no difference in hyperkalemia between groups (RR 0.87; 95% CI, 0.59-1.27; P = 0.46). Conclusions. Compared with saline, BES reduces the risk of DGF in deceased donor kidney transplantation without increasing hyperkalemia.
format Article
id doaj-art-70f900823a894d5f9de8acd0033ff9fd
institution OA Journals
issn 2373-8731
language English
publishDate 2025-01-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj-art-70f900823a894d5f9de8acd0033ff9fd2025-08-20T02:00:02ZengWolters KluwerTransplantation Direct2373-87312025-01-01111e168710.1097/TXD.0000000000001687202501000-00004Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysisSusan S. Wan, MBBS, MMed (Clin Epi), FRACP, PhD0Kate Wyburn, MBBS, FRACP, PhD1Steven J. Chadban, PhD, FRACP, FAHMS2Michael G. Collins, MBChB, FRACP, PhD31 Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.1 Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.1 Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.4 Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia.Background. Perioperative intravenous fluids are administered to kidney transplant recipients to maintain hemodynamic stability and graft perfusion; however, the ideal fluid remains uncertain. Although 0.9% saline (saline) is commonly used, its high chloride content causes hyperchloremic metabolic acidosis and may increase the risks of delayed graft function (DGF) and hyperkalemia. Balanced electrolyte solutions (BES) have a more physiological chloride concentration and may reduce these risks. Previous meta-analyses found insufficient evidence to compare BES with saline for these outcomes; however, new studies have recently been published. In this updated review, we compared the effects of BES with saline on the risk of DGF and hyperkalemia in kidney transplantation. Methods. MEDLINE, Embase, and CENTRAL were searched for randomized controlled trials comparing BES with saline in kidney transplantation. The primary outcomes were DGF and hyperkalemia. Eligible studies were assessed for risk of bias and data were pooled for analysis. The Grading of Recommendations Assessment, Development, and Evaluation framework was used to assess the quality of evidence. Results. Ten studies involving 1532 participants were included. The quality of evidence was high for deceased donor transplantation and very low for living donor transplantation. The relative risk (RR) of DGF associated with BES compared with saline was 0.83 (95% confidence interval [CI], 0.71-0.96; P = 0.01) in deceased donor transplantation. There was no difference in DGF in living donor transplantation (RR 0.79; 95% CI, 0.26-2.41; P = 0.68). There was no difference in hyperkalemia between groups (RR 0.87; 95% CI, 0.59-1.27; P = 0.46). Conclusions. Compared with saline, BES reduces the risk of DGF in deceased donor kidney transplantation without increasing hyperkalemia.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001687
spellingShingle Susan S. Wan, MBBS, MMed (Clin Epi), FRACP, PhD
Kate Wyburn, MBBS, FRACP, PhD
Steven J. Chadban, PhD, FRACP, FAHMS
Michael G. Collins, MBChB, FRACP, PhD
Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
Transplantation Direct
title Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
title_full Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
title_fullStr Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
title_full_unstemmed Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
title_short Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
title_sort balanced electrolyte solutions versus 0 9 saline for kidney transplantation an updated systematic review and meta analysis
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001687
work_keys_str_mv AT susanswanmbbsmmedclinepifracpphd balancedelectrolytesolutionsversus09salineforkidneytransplantationanupdatedsystematicreviewandmetaanalysis
AT katewyburnmbbsfracpphd balancedelectrolytesolutionsversus09salineforkidneytransplantationanupdatedsystematicreviewandmetaanalysis
AT stevenjchadbanphdfracpfahms balancedelectrolytesolutionsversus09salineforkidneytransplantationanupdatedsystematicreviewandmetaanalysis
AT michaelgcollinsmbchbfracpphd balancedelectrolytesolutionsversus09salineforkidneytransplantationanupdatedsystematicreviewandmetaanalysis